Anne Staunton Adams's Contact Details

Anne Staunton Adams's Company Details

USAgainstAlzheimer's

Washington, DC, US • 20 - 49 Employees
Non-Profit

The number-one goal of UsAgainstAlzheimer's (UsA2), an innovative 501(c)3 organization, is to stop Alzheimer's disease (AD). Driven by the suffering of millions of families, UsA2 (and its partner 501(c)4 organization, UsA2 Action) is pressing for greater urgency from government, industry and the scientific community in the quest for an Alzheimer's cure—accomplishing this through effective leadership, collaborative advocacy and strategic investments. Our objectives are to:● Increase public and private resources for Alzheimer's research● Increase the speed, efficiency, and diversity of clinical trials for Alzheimer's disease● Increase attention to brain health to delay onset of Alzheimer's and increase early detection, diagnosis, and treatment of Alzheimer's● Include insights and preferences of individuals living with Alzheimer's and their care partners in drug development, regulatory and Medicare decisions● Help advance national care goals and policies in support of individuals living with Alzheimer's and their care partners● Mobilize Americans to demand an effective, accessible treatment● Reduce AD's disparate impact on women & minoritiesWe believe that accomplishing these objectives will require bringing all of us to the fight. As a result, keys to our work are advocating, convening and collaborating—with those living with the disease, government, other advocacy groups, industry, researchers, and thought leaders. Founded in 2010, UsA2 is making a transition from being an organization led primarily by the co-founders to one that is more sustainable and program-focused.